155
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Confusion and Hallucination in a Geriatric Patient. Pitfalls of a Rare Differential: Case Report of an Anti-LGI1-Encephalitis

, , & ORCID Icon
Pages 1423-1432 | Received 07 Jul 2022, Accepted 05 Sep 2022, Published online: 13 Nov 2023

References

  • Ukkonen M, Jämsen E, Zeitlin R, Pauniaho SL. Emergency department visits in older patients: a population-based survey. BMC Emerg Med. 2019;19(1):20. doi:10.1186/s12873-019-0236-3
  • Grossman M, Irwin DJ. The mental status examination in patients with suspected dementia. Contin Minneap Minn. 2016;22(2Dementia):385–403.
  • Paik SH, Ahn JS, Min S, Park KC, Kim MH, Guloksuz S. Impact of psychotic symptoms on clinical outcomes in delirium. PLoS One. 2018;13(7):e0200538. doi:10.1371/journal.pone.0200538
  • Khouzam HR, Emes R. Late life psychosis: assessment and general treatment strategies. Compr Ther. 2007;33(3):127–143. doi:10.1007/s12019-007-0016-y
  • Liew TM. Neuropsychiatric symptoms in cognitively normal older persons, and the association with Alzheimer’s and non-Alzheimer’s dementia. Alzheimers Res Ther. 2020;31(12):35. doi:10.1186/s13195-020-00604-7
  • Banks SA, Sechi E, Flanagan EP. Autoimmune encephalopathies presenting as dementia of subacute onset and rapid progression. Ther Adv Neurol Disord. 2021;14:175628642199890. doi:10.1177/1756286421998906
  • Dubey D, Pittock SJ, Kelly CR, et al. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol. 2018;83(1):166–177. doi:10.1002/ana.25131
  • Abboud H, Probasco JC, Irani S, et al. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry. 2021;92(7):757–768. doi:10.1136/jnnp-2020-325300
  • Bradshaw MJ, Linnoila JJ. An Overview of Autoimmune and Paraneoplastic Encephalitides. Semin Neurol. 2018;38(3):330–343. doi:10.1055/s-0038-1660821
  • Dalmau J, Armangué T, Planagumà J, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. 2019;18(11):1045–1057. doi:10.1016/S1474-4422(19)30244-3
  • van Sonderen A, Schreurs MWJ, Wirtz PW, Sillevis Smitt PAE, Titulaer MJ. From VGKC to LGI1 and Caspr2 encephalitis: the evolution of a disease entity over time. Autoimmun Rev. 2016;15(10):970–974. doi:10.1016/j.autrev.2016.07.018
  • Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391–404. doi:10.1016/S1474-4422(15)00401-9
  • Thompson J, Bi M, Murchison AG, et al. The importance of early immunotherapy in patients with faciobrachial dystonic seizures. Brain. 2018;141(2):348–356. doi:10.1093/brain/awx323
  • Hayden Z, Bóné B, Orsi G, et al. Clinical characteristics and outcome of neuronal surface antibody-mediated autoimmune encephalitis patients in a national cohort. Front Neurol. 2021;12:611597. doi:10.3389/fneur.2021.611597
  • van Sonderen A, Thijs RD, Coenders EC, et al. Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up. Neurology. 2016;87(14):1449–1456. doi:10.1212/WNL.0000000000003173
  • Escudero D, Guasp M, Ariño H, et al. Antibody-associated CNS syndromes without signs of inflammation in the elderly. Neurology. 2017;89(14):1471–1475. doi:10.1212/WNL.0000000000004541
  • Ariño H, Armangué T, Petit-Pedrol M, et al. Anti-LGI1–associated cognitive impairment. Neurology. 2016;87(8):759–765. doi:10.1212/WNL.0000000000003009
  • Wang M, Cao X, Liu Q, Ma W, Guo X, Liu X. Clinical features of limbic encephalitis with LGI1 antibody. Neuropsychiatr Dis Treat. 2017;13:1589–1596. doi:10.2147/NDT.S136723
  • Hoorn EJ, Zietse R. Diagnosis and treatment of hyponatremia: compilation of the guidelines. J Am Soc Nephrol. 2017;28(5):1340–1349. doi:10.1681/ASN.2016101139
  • Irani SR, Michell AW, Lang B, et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol. 2011;69(5):892–900. doi:10.1002/ana.22307
  • Simabukuro MM, Nóbrega PR, Pitombeira M, et al. The importance of recognizing faciobrachial dystonic seizures in rapidly progressive dementias. Dement Neuropsychol. 2016;10(4):351–357. doi:10.1590/s1980-5764-2016dn1004016
  • Flanagan EP, Kotsenas AL, Britton JW, et al. Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures. Neurol Neuroimmunol Neuroinflam. 2015;2(6):e161. doi:10.1212/NXI.0000000000000161
  • Qiao S, Wu HK, Liu LL, et al. Clinical features and long-term outcomes of anti-leucine-rich glioma-inactivated 1 encephalitis: a multi-center study. Neuropsychiatr Dis Treat. 2021;17:203–212. doi:10.2147/NDT.S292343
  • Swiss DR. Regeln und Definitionen zur Fallabrechnung unter SwissDRG und TARPSY; 2019.
  • Cohen J, Sotoca J, Gandhi S, et al. Autoimmune encephalitis: a costly condition. Neurology. 2019;92(9):e964–e972. doi:10.1212/WNL.0000000000006990